Cookies used for improved website experience

Siemens Healthineers and our partners use cookies and other similar technologies to operate the Siemens Healthineers websites and personalize content and ads. You may find out more about how we use cookies by clicking "Show details" or by referring to our Cookie Policy.
You may allow all cookies or select them individually. And you may change your consent and cookie preferences anytime by clicking on the "Review and change your consent" button on the Cookie Policy page.

The value of PET/CT for melanoma

By Munir Ghesani, MD, FACNM, FACR, New York, NY, USA.

|2019-04-04

Melanoma is a malignant neoplasm of the skin, originating from the melanocyte. With melanoma being, in general, robustly FDG-avid, FDG PET/CT is shown to be a very valuable imaging tool in the assessment and treatment response of the cancer. Download the white paper to get a closer understanding of the growing literature demonstrating the remarkable utility of FDG PET/CT in melanoma in addition to access of national cancer management guidelines and current reimbursement policies.